Amy E. Baxter
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Virology top 1%
- HIV Research and Treatment
Papers in
- Virology 16
- HIV Research and Treatment 16
-
- SARS-CoV-2 and COVID-19 Research 11
- COVID-19 Clinical Research Studies 6
- Co-authors
- Jean‐Pierre Routy (8 shared papers)Nathalie Brassard (8 shared papers)Rémi Fromentin (5 shared papers)Nicolas Chomont (6 shared papers)Julia Niessl (8 shared papers)Andrés Finzi (5 shared papers)Marta Massanella (3 shared papers)E. John Wherry (10 shared papers)
- Journals
- Science Immunology (6 papers)Nature Immunology (5 papers)Cell (5 papers)Immunity (4 papers)Retrovirology (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Amy E. Baxter
47 papers receiving 7.8k citations
Amy E. Baxter's Hit Papers
Peers
Comparison fields: 5 of 118
- Infectious Diseases 4k
- Virology 936
- Immunology 1.3k
- Oncology 876
- Neurology 301
Countries citing papers authored by Amy E. Baxter
This map shows the geographic impact of Amy E. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Baxter more than expected).
Fields of papers citing papers by Amy E. Baxter
This network shows the impact of papers produced by Amy E. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Baxter. The network helps show where Amy E. Baxter may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy E. Baxter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications Hit paper breakdown → | 2020 | 1226 |
| 2 | mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Hit paper breakdown → | 2021 | 682 |
| 3 | 2020 | 594 | |
| 4 | TCF-1-Centered Transcriptional Network Drives an Effector versus Exhausted CD8 T Cell-Fate Decision Hit paper breakdown → | 2019 | 550 |
| 5 | Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination Hit paper breakdown → | 2021 | 514 |
| 6 | CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer Hit paper breakdown → | 2021 | 412 |
| 7 | Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination Hit paper breakdown → | 2021 | 392 |
| 8 | Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection Hit paper breakdown → | 2021 | 319 |
| 9 | 2017 | 252 | |
| 10 | Serotonin reduction in post-acute sequelae of viral infection Hit paper breakdown → | 2023 | 251 |
| 11 | 2019 | 182 | |
| 12 | 2022 | 177 | |
| 13 | 2021 | 172 | |
| 14 | 2016 | 164 | |
| 15 | Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine Hit paper breakdown → | 2022 | 163 |
| 16 | 2021 | 156 | |
| 17 | 2014 | 141 | |
| 18 | 2014 | 134 | |
| 19 | 2020 | 131 | |
| 20 | 2020 | 99 |
About Amy E. Baxter
Amy E. Baxter is a scholar working on Virology, Infectious Diseases, Immunology, Oncology and Molecular Biology, having authored 51 papers that have together received 7.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (16 papers), T-cell and B-cell Immunology (13 papers), SARS-CoV-2 and COVID-19 Research (11 papers), COVID-19 Clinical Research Studies (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Kawasaki Disease and Coronary Complications (3 papers), Genomics and Chromatin Dynamics (2 papers) and Single-cell and spatial transcriptomics (2 papers). The work is most often cited by research in Infectious Diseases (4k citations), Virology (936 citations), Immunology (1.3k citations), Oncology (876 citations) and Neurology (301 citations). Amy E. Baxter has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Jean‐Pierre Routy, Nathalie Brassard, Rémi Fromentin, Nicolas Chomont, Julia Niessl, Andrés Finzi, Marta Massanella, E. John Wherry, Antigoni Morou and Josephine Ruth Giles. Their work appears in journals such as Science Immunology, Nature Immunology, Cell, Immunity and Retrovirology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.